BJOG. 2018 Feb 20. doi: 10.1111/1471-0528.15171. [Epub ahead of print]
Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients: analysis of the Scottish real life experience.
Rust K1, Spiliopoulou P2, Tang CY3, Bell C4, Stirling D5, Phang THF6, Davidson R7, Mackean M1, Nussey F1, Glasspool R2, Reed N2, Sadozye A2, Porteous M5, McGoldrick T8, Ferguson M3, Miedzybrodzka Z4,6, McNeish IA2,9, Gourley C1,10.
MAIN OUTCOME MEASURES:
This article is protected by copyright. All rights reserved.
BRCA1; BRCA2; RAD51C; RAD51D; ovarian cancer